Have a personal or library account? Click to login
Clinico-Epidemiological Profile and Assessment of Quality of Life of Patients with Chronic Spontaneous Urticaria from Tertiary Care Hospital: A Cross-Sectional Study Cover

Clinico-Epidemiological Profile and Assessment of Quality of Life of Patients with Chronic Spontaneous Urticaria from Tertiary Care Hospital: A Cross-Sectional Study

By: S. Goel,  S. Malhan,  H. Kaur,  D. Chopra and  S. Gupta  
Open Access
|Jun 2025

References

  1. Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy 2018;73(7):1393-414.
  2. Godse K, De A, Zawar V, et al. Consensus statement for the diagnosis and treatment of urticaria: a 2017 update. Indian J Dermatol 2018;63(1):2-15.
  3. Peck G, Hashim MJ, Shaughnessy C, et al. Global Epidemiology of Urticaria: Increasing Burden among Children, Females and Low-income Regions. Acta Derm Venereol. 2021;101(4):adv00433.
  4. Gabrielle PE, Hashim MJ, Shaughnessy C, et al. Global epidemiology of urticaria: increasing burden among children, females and low-income regions. Acta Derm Venereol 2021;101(4).
  5. Liu X, Cao Y, Wang W. Burden of and Trends in Urticaria Globally, Regionally, and Nationally from 1990 to 2019: Systematic Analysis. JMIR Public Health Surveill 2023;9:e50114.
  6. Weller K, Maurer M, Bauer A, et al. Epidemiology, comorbidities, and healthcare utilization of patients with chronic urticaria in Germany. J Eur Acad Dermatol Venereol. 2022; 36(1):91-9.
  7. Bozek A, Krajewska J, Filipowska B, et al. HLA status in patients with chronic spontaneous urticaria. Int Arch Allergy Immunol. 2010; 153(4):419-23.
  8. Gruber BL, Baeza ML, Marchese MJ, et al. Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol 1988;90(2):213-7.
  9. Godse KV. Urticaria meter. Indian J Dermatol. 2012;57(5):410-1.
  10. Vohra S, Sharma NL, Mahajan VK, Shanker V. Clinicoepidemiologic features of chronic urticaria in patients having positive versus negative autologous serum skin test: a study of 100 Indian patients. Indian J Dermatol Venereol Leprol. 2011;77(2):156-9.
  11. Alwafa HO, Farag M. Evaluation of plasma d-dimer level in patients with chronic urticaria. J Dermat Cosmetol. 2019;3(1):7-11.
  12. Mariyath OKR, Sukumarakurup S, Pinky SRR, et al. A descriptive study of clinic-epidemiological profile of chronic urticaria from a tertiary care center. Int J Res Dermatol 2021;7(2):184-7.
  13. Joseph N, Suman A, Dangayach S, et al. A clinico-epidemiological study on urticaria cases in various tertiary care hospitals affiliated to a medical college in Mangalore, India. Indian J Allergy Asthma Immunol. 2019;33(1):32-8.
  14. Dabas G, Thakur V, Bishnoi A, et al. Causal relationship between D-dimers and disease status in chronic spontaneous urticaria and adjuvant effect of oral tranexamic acid. Indian Dermatol Online Journal. 2021;12(5):726-30.
  15. Nguyen HT, Vu TT. Plasma D-dimer level in Vietnamese patients with chronic urticaria. Indian J Dermatol. 2021;66(5):496-500.
  16. Tirupathi UR, Manchiryala BR, Kareddy S. Association between Clinico-Epidemiological Features in Chronic Urticaria with Autologous Serum Skin Test: A Cross-sectional Observational Study. J Clin Diagn Res . 2021;15(7) WC01-4.
  17. Khursheed U, Shah S, Aslam A, et al. D-dimer levels in patients with chronic urticaria: A case–control study on a Kashmiri population. Our Dermatology Online. 2022;13(4)365-7.
  18. Wang X, Liu LJ, Li LF, et al. Clinical features of urticaria: results from a hospital-based multicenter study in China. Front Med. 2022; 9:899857.
  19. Kocatürk E, Salameh P, Sarac E, et al. Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study. J Allergy Clin Immunol. 2023 Nov;152(5):1095-1106.
  20. Sadowska-Przytocka A, Czarnecka-Operacz M, Łącka K, et al. The relationship between the severity of clinical symptoms of chronic urticaria and serum D-dimer levels. Postąpy Dermatol Alergol. 2020;38(3):486-9.
  21. Metwalli M, Khattab F, Zidan AA. Plasma D-dimer as a biomarker of chronic urticaria treatment. Al-Azhar Assiut Med J. 2019;17(3):222-6.
  22. Paudel S, Parajuli N, Sharma RP, Dahal S, Paudel S. Chronic Urticaria and Its Impact on the Quality of Life of Nepalese Patients. Dermatol Res Pract. 2020 Nov 28;2020:6694191.
  23. Basra MK, Salek MS, Camilleri L, et al. Determining the minimal clinically important difference and responsiveness of the Dermatology Life Quality Index (DLQI): further data. Dermatology 2015; 230:27–33.
  24. Staevska M, Popov TA, Kralimarkova T, et al. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. J Allergy Clin Immunol. 2010;125(3):676-82.
DOI: https://doi.org/10.2478/amb-2025-0040 | Journal eISSN: 2719-5384 | Journal ISSN: 0324-1750
Language: English
Page range: 24 - 29
Submitted on: Sep 11, 2024
Accepted on: Nov 21, 2024
Published on: Jun 19, 2025
Published by: Sofia Medical University
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 S. Goel, S. Malhan, H. Kaur, D. Chopra, S. Gupta, published by Sofia Medical University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.